8-KLeadership Changes

Johnson Controls International plc 8-K Report, Executive Changes (May 13, 2026)

Filed May 13, 2026For Securities:JCI

Summary

Johnson Controls International plc (JCI) announced the adoption of a new Value Growth Incentive Program (VGI Program) effective May 11, 2026. This program is designed to incentivize and retain key executive talent by linking a significant portion of their compensation to aggressive, long-term growth and shareholder value creation. The VGI Program utilizes performance-based share options and share appreciation rights, with vesting contingent on achieving ambitious net sales and market capitalization targets over a five-year period, spanning fiscal years 2026 through 2030. This initiative signals the company's commitment to driving substantial increases in revenue and market valuation, going beyond current performance expectations. The performance metrics are dual-natured: 50% of the incentive is tied to achieving a significant net sales growth target (relative to FY2025) coupled with a substantial increase in market capitalization. The remaining 50% is directly linked to achieving a specified market capitalization goal. The program's structure emphasizes that executive compensation is aligned with delivering superior shareholder returns and long-term company performance, with options only gaining value if the company's share price appreciates.

Key Highlights

  • 1Adoption of a new Value Growth Incentive Program (VGI Program) to align executive compensation with long-term shareholder value creation.
  • 2VGI Program grants performance-based share options and share appreciation rights to key executives.
  • 3Vesting is contingent on achieving ambitious net sales growth and market capitalization targets over a five-year period (FY2026-FY2030).
  • 4Performance goals require significant increases beyond current company expectations.
  • 550% of incentives tied to net sales growth and market capitalization; 50% tied to market capitalization achievement.
  • 6Awards have an exercise price equal to the share price on the grant date, meaning value is derived from future share price appreciation.
  • 7Specific grants approved for CEO ($10.5M target value) and other key executives (each $5.3M target value) with a grant date of May 15, 2026.

Frequently Asked Questions